These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30956015)

  • 1. [How to reduce rapidly destruction of labile blood components at the health facilities level? The experience of Centre Hospitalier de la Côte Basque].
    Bauduer F; Recanzone H; Harcaut N; Hoquet PM; Larricq D
    Transfus Clin Biol; 2019 Nov; 26(4):263-265. PubMed ID: 30956015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of causes of destruction of labile blood products in health institutions: A multicentric study].
    Damais-Cepitelli A; Leo-Kodeli S; Lovi V; Gouëzec H; Lassale B; Augey L; Berger E; Betbèze V; Bourcier V; Daurat G; Ducroz S; Huchet C; Le Niger C; Pujol S; Puntous M;
    Transfus Clin Biol; 2018 Nov; 25(4):242-248. PubMed ID: 30145111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective study of the causes for destruction of labile blood products during 1999 at a University Hospital Center].
    Benz-Lemoine E; Baloge B; Dupuis M; Champagne X; Pradeau F; Redersdorff JC
    Transfus Clin Biol; 2001 Dec; 8(6):460-6. PubMed ID: 11802607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Utmost Vital Emergency (UVE) blood transfusion from 2010 to 2014 in the French establishment of the Blood Centre Atlantique.
    Sapey T; Lele I; Jutant T; Py JY; Dehaut F
    Transfus Clin Biol; 2015; 22(5-6):352-3. PubMed ID: 26584783
    [No Abstract]   [Full Text] [Related]  

  • 5. [Techniques of preparation and indications of labile blood products].
    Clément S
    Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
    Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
    Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How do I assess requirement of a blood bank and its kind for a healthcare establishment?].
    Lafeuillade B; Tixier A; Bliem C; Meyer F
    Transfus Clin Biol; 2014 Dec; 21(6):296-302. PubMed ID: 25441456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with the regionalization of transfusion advice].
    Courbil R; Fabrigli P; Benamara H; Chavarin P; Bregeon M; Ruyer-Dumontier P; Goure D; Paulin P; Froget A; Taibi K; Rigal E; Garraud O
    Transfus Clin Biol; 2009 Mar; 16(1):4-11. PubMed ID: 19324582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive survey of red blood cell unit life cycle at a large teaching institution in eastern Canada.
    Cheng CK; Trethewey D; Sadek I
    Transfusion; 2010 Jan; 50(1):160-5. PubMed ID: 19761550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood transfusion in emergency settings: French military health service experience].
    Sailliol A; Ausset S; Peytel E
    Transfus Clin Biol; 2010 Dec; 17(5-6):279-83. PubMed ID: 21051268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [French haemovigilance from 1994 to nowadays: Evolution and prospects].
    Lassale B; Daurat G; Besse-Moreau M; Aullen JP
    Transfus Clin Biol; 2017 Sep; 24(3):268-272. PubMed ID: 28647104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of quality control for improvement of blood components in the Regional Blood Centre of Ouagadougou in Burkina Faso, 2014].
    Nebie K; Sawadogo S; Kafando E; Bationo EM; Dahourou H; Ouattara S; Kienou K; Nana S; Kaba L; Fretz C; Murphy EL
    Transfus Clin Biol; 2017 Nov; 24(4):431-439. PubMed ID: 28583468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Failures of the issue: how to improve?].
    Legrand D; François A
    Transfus Clin Biol; 2013 May; 20(2):104-8. PubMed ID: 23601198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of depots for blood products in health establishments. Management of labile blood products, supplies, tracking].
    Sourimant Y
    Transfus Clin Biol; 2005 Jun; 12(2):186-90. PubMed ID: 15950891
    [No Abstract]   [Full Text] [Related]  

  • 17. [Are the indications and choice of labile blood products adapted? National survey on prescriber's knowledge].
    Rieux C; Bastuji-Garin S; Vicariot M; Chenais F; Courtois F; Waller C; Quaranta JF; Bierling P;
    Presse Med; 2003 Sep; 32(29):1352-8. PubMed ID: 14534496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Roundtables of SFTS Congress 2013: Needs, indications and safety of blood products; self-sufficiency in blood products].
    Hermine O; Lassale B; Morel P; Samama CM; Folléa G; Monsellier M; Noël S; Tissot JD; Lefrère JJ
    Transfus Clin Biol; 2014 Jun; 21(3):120-31. PubMed ID: 24906893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The organizational issues of the blood transfusion service operation].
    Polunina NV; Oprishchenko SA
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2009; (1):36-8. PubMed ID: 19385080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District.
    Kubio C; Tierney G; Quaye T; Nabilisi JW; Ziemah C; Zagbeeb SM; Shaw S; Murphy WG
    Transfusion; 2012 Oct; 52(10):2161-6. PubMed ID: 22612858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.